Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007

H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 101. EXPANSION OF BIOMEDICAL RESEARCH Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis. Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research. Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities. Requires a report to Congress not later than 180 days after the convening of summit.

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Access to care for people with psoriasis and psoriatic arthritis H.R. 1188 and S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following: (1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis; (2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis; (3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state.

Client expense: $100,000 · Firm income: Not reported

H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 101. EXPANSION OF BIOMEDICAL RESEARCH Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis. Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research. Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities. Requires a report to Congress not later than 180 days after the convening of summit.

Client expense: $56,012 · Firm income: Not reported

Access to care for people with psoriasis and psoriatic arthritis H.R. 1188 and S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following: (1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis; (2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis; (3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state.

Client expense: $56,012 · Firm income: Not reported

H.R. 1188/S. 1459, The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act; Psoriasis Awareness Month

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1192: S. 1359: Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368: Personalized Health Information Act of 2007

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1188/S. 1459, The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1192: S. 1359: Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368: Personalized Health Information Act of 2007

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Access to care for people with psoriasis and psoriatic arthritis H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following: (1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis; (2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis; (3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state.

Client expense: $172,846 · Firm income: Not reported

H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 101. EXPANSION OF BIOMEDICAL RESEARCH Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis. Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research. Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities. Requires a report to Congress not later than 180 days after the convening of summit.

Client expense: $172,846 · Firm income: Not reported

H.R. 1192: S. 1359: Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368: Personalized Health Information Act of 2007

Client expense: Not reported · Firm income: $60,000

H.R. 1192: S. 1359: Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368: Personalized Health Information Act of 2007

Client expense: Not reported · Firm income: $60,000

Access to care for people with psoriasis and psoriatic arthritis H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following: (1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis; (2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis; (3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state.

Client expense: $127,000 · Firm income: Not reported

H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 101. EXPANSION OF BIOMEDICAL RESEARCH Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis. Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research. Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities. Requires a report to Congress not later than 180 days after the convening of summit.

Client expense: $127,000 · Firm income: Not reported

H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1188/S. 1459, The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R.1192 Lupus Research, Education, Awareness, Communication and Health Care Amendements of 2007; S.1359: Lupus Research, Education, Awareness, Communication and Health Care Amendments of 2007; H.R.1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; S.1459 Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007; H.R.1368: Personalized Health Information Act of 2007

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, UNDETERMINED

H.R. 945, the Tanning Accountability Accountability and Notification Act of 2007; H.R. 1093, the Resident Physician Shortage Reduction Act of 2007; H.R. 1188, the Psoriasis and Psoriatic Arthritis Research, Care and Cure Act of 2007; H.R. 2406, a bill to authorize the NIST to increase efforts in support of the integration of healthcare enterprise in the U.S.; H.R. 2749, the Voluntary Medicare Quality Reporting Act of 2007; H.R. 2900, PDUFA of 2007; H.R. 3162 the SCHIP Act of 2007; HHS Appropriations Act

Client expense: $260,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office

H.R. 1192: Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 S. 1359: Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459: Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368: Personalized Health Information Act of 2007

Client expense: Not reported · Firm income: $120,000

* Access to care for people with psoriasis and psoriatic arthritis H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 2842 Childrens Health Protection Act of 2007 S. 2236 Childrens Health Protection Act of 2007 H.R. 2842 Childrens Health Protection Act of 2007 S. 2236 Childrens Health Protection Act of 2007

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007

Client expense: $100,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1188/S. 1459, The Psoriasis & Psoriatic Arthritis Research, Cure and Care Act S. Res. 116 National AutoImmune Disease Awareness Month H. Res. 17 National Inflamatory Skin Disease Awareness Month

Client expense: Not reported · Firm income: $80,000

(cont'd) (6) H.R. 2900, the Prescription Drug User Fee Amendments of 2007, (7) H.R. 3162, the Children's Health and Medicare Protection Act of 2007, and (8) the Departments of Labor, Health and Human Servivces, and Education and Related Agencies Appropriations Act of 2007. (1) H.R. 945, the Tanning Accountability and Notification Act of 2007, (2) H.R. 1093, the Resident Physician Shortage Reduction Act of 2007, (3) H.R. 1188, the Psoriasis and Psoriatic Arthritis Reseach, Care and Cure Act of 2007, (4) H.R. 2406, a bill to authorize the National Insitutes of Standards and Technology to increase its efforts in support of the integration of healthcare enterprise in the United States, (5) H.R. 2749, the Voluntary Medicare Quality Reporting Act of 2007, [continued on next page]

Client expense: $492,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 104. STUDY AND REPORT BY THE INSTITUTE OF MEDICINE • Directs the HHS Secretary to enter into a contract with the Institute of Medicine (IOM) to conduct a study to evaluate and make recommendations to address the following: (1) The extent to which public and private insurers cover prescription medications and other treatments for psoriasis and psoriatic arthritis; (2) The payment structures, such as deductibles and co-payments, amounts and duration of the coverage and payments under health plans and their adequacy to cover the costs of providing ongoing care to patients with psoriasis and psoriatic arthritis; (3) Health plan and insurer coverage policies and practices and their impact on patient access to the best regimen and most appropriate care for their particular disease state. Access to care for people with psoriasis and psoriatic arthritis H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007

Client expense: $180,000 · Firm income: Not reported

S.Res.116, A resolution designating May 2007 as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. H.Res.258, Expressing the sense of the House of Representatives that there should be established a National Autoimmune Diseases Awareness Month and for other purposes H.R.1188 and S.1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 Section 101. EXPANSION OF BIOMEDICAL RESEARCH • Directs the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to expand and intensify research on psoriasis and psoriatic arthritis. • Directs NIAMS to coordinate with other National Institutes of Health (NIH) centers, institutes, and offices with respect to psoriasis and psoriatic arthritis research. Section 102. STRENGTHENING PSORIASIS AND PSORIATIC ARTHRITIS EPIDEMIOLOGY • Directs the Centers for Disease Control and Prevention (CDC), in collaboration with a national organization expert in the epidemiology of psoriasis and psoriatic arthritis, to establish a national psoriasis and psoriatic arthritis patient registry. Section 103. PSORIASIS AND PSORIATIC ARTHRITIS CO-MORBIDITIES CONDITIONS SUMMIT • Directs the Department of Health and Human Services (HHS) to convene a summit of researchers, public health professionals, patient advocacy organizations, academic institutions, and Federal and State policymakers to provide a detailed overview of current efforts in psoriasis and psoriatic arthritis research, treatment, quality of life, and other such activities at the NIH, CDC, the Agency for Healthcare Research and Quality, the Substance Abuse and Mental Health Services Administration, and the Health Resources and Services Administration, and other federal agencies whose work involves psoriasis and psoriatic arthritis related co-morbidities. • Requires a report to Congress – not later than 180 days after the convening of summit. H.R. 1188, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 S. 1459, Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007

S.626/H.R.1283 - Arthritis Prevention, Control, and Cure Act of 2007 S. 1893: Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162: Children's Health and Medicare Protection Act of 2007 CMS-1385-P: CY2008 Physician Fee Schedule Sustainable Growth Rate Issues Pay for Performance Issues H. R. 1293 - Access to Medicare Imaging Act of 2007 H.R. 583/S.1042 - Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007 DEXA (Imaging Reductions) H.R. 2931 - Osteoporosis Early Detection and Prevention Act of 2007 H.R. 2340 - Medicare Osteoporosis Measurement Act of 2007 H.R. 1192/S. 1359 - Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188/S. 1459 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368 - Personalized Health Information Act of 2007 S. 1693 - Wired for Health Care Quality Act H.R. 1190/S. 1750 - Community Cancer Care Preservation Act of 2007

Client expense: Not reported · Firm income: $120,000

Bone disease issues H.R. 2931 - Osteoporosis Early Detection and Prevention Act of 2007 H.R. 2340 - Medicare Osteoporosis Measurement Act of 2007 S.626/H.R.1283 - Arthritis Prevention, Control, and Cure Act of 2007 FY 2008 Labor, HHS, Education Appropriations: Funding for research care for rheumatic diseases H.R. 1192/S. 1359 - Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188/S. 1459 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368 - Personalized Health Information Act of 2007 S. 1693 - Wired for Health Care Quality Act H.R. 1190/S. 1750 - Community Cancer Care Preservation Act of 2007

Client expense: Not reported · Firm income: $120,000

Osteoporosis Screening S.626/H.R.1283 - Arthritis Prevention, Control, and Cure Act of 2007 S. 1893: Children's Health Insurance Program Reauthorization Act of 2007 H.R. 3162: Children's Health and Medicare Protection Act of 2007 CMS-1385-P: CY2008 Physician Fee Schedule Sustainable Growth Rate Issues - See MMM Pay for Performance Issues H. R. 1293 - Access to Medicare Imaging Act of 2007 H.R. 583/S.1042 - Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007 DEXA (Imaging Reductions) FY 2008 Labor, HHS, Education Appropriations: Funding for research care for rheumatic diseases H.R. 2931 - Osteoporosis Early Detection and Prevention Act of 2007 H.R. 2340 - Medicare Osteoporosis Measurement Act of 2007 S. 1695: Biologics Price Competition and Innovation Act of 2007 S. 1082/H.R. 2900 - FDA reauthorization Legislation H.R. 1192/S. 1359 - Lupus Research, Education, Awareness, Communication, and Health Care Amendments of 2007 H.R. 1188/S. 1459 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2007 H.R. 1368 - Personalized Health Information Act of 2007 S. 1693 - Wired for Health Care Quality Act H.R. 1190/S. 1750 - Community Cancer Care Preservation Act of 2007

Client expense: Not reported · Firm income: $120,000

H.R. 1188/S. 1459, The Psoriasis & Psoriatic Arthritis Research, Cure and Care Act S. Res. 116 National AutoImmune Disease Awareness Month H. Res. 17 National Inflamatory Skin Disease Awareness Month

Client expense: Not reported · Firm income: $80,000